Black Diamond Therapeutics Inc (BDTX)

[FACT-MASTER]

Back last December, i was sort of thinking 1535 data would be coming in the first half of 2023 - recurrent GBM monotherapy cohorts.

However, the additional cohort of patients added and being treated by the combo of BDTX-1535 and Temozolomide, I think will delay the overall release of data.

Is there anyway to determine if BDTX submitted an abstract for WCLC 2023 / or if the agenda is available yet?

Just going back to your link regarding the trial site changes here:
https://clinicaltrials.gov/ct2/history/NCT05256290?A=12&B=13&C=Side-by-Side#StudyPageTop

Scroll down to the Korea, Republic of, and what i found of interest was the involvement of the Samsung Medical Clinic, contact - Dr.DoHyun Nam

https://www.samsunghospital.com/gb/language/m_english/common/doctorProfile.do?dr_no=361

https://www.samsunghospital.com/gb/language/m_english/common/doctorProfile.do?dr_no=361

Impressive involvement for BDTX, in the 1535 clinical trial, imo.